Gao Zhang, Ph.D.

Affiliations: 
2012 Bioengineering University of Pennsylvania, Philadelphia, PA, United States 
Area:
Biomedical Engineering, Oncology, Cell Biology
Google:
"Gao Zhang"

Parents

Sign in to add mentor
Meenhard Herlyn grad student 2012 Penn
 (Induction of cellular senescence as a novel therapeutic strategy for melanoma treatment.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Buj R, Chen CW, Dahl ES, et al. (2019) Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming. Cell Reports. 28: 1971-1980.e8
Aloia A, Müllhaupt D, Chabbert CD, et al. (2019) A fatty acid oxidation-dependent metabolic shift regulates the adaptation of -mutated melanoma to MAPK inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Liu S, Zhang G, Guo J, et al. (2019) Author Correction: Loss of Phd2 cooperates with BRAF to drive melanomagenesis. Nature Communications. 10: 1211
Sahu AD, S Lee J, Wang Z, et al. (2019) Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Molecular Systems Biology. 15: e8323
Atay C, Kwak T, Lavilla-Alonso S, et al. (2019) BRAF targeting sensitizes resistant melanoma to cytotoxic T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Liu S, Zhang G, Guo J, et al. (2018) Loss of Phd2 cooperates with BRAF to drive melanomagenesis. Nature Communications. 9: 5426
Ojha R, Leli NM, Onorati A, et al. (2018) ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discovery
Lu H, Liu S, Zhang G, et al. (2018) Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas. Nature
Rebecca VW, Nicastri MC, Fennelly C, et al. (2018) PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discovery
Jerby-Arnon L, Shah P, Cuoco MS, et al. (2018) A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell. 175: 984-997.e24
See more...